I have a question about billing for the technical component on leukemia/lymphoma workups. The state of the art in gating strategy requires the use of multiple aliquots of the same antibody. What is the standard practice for billing for these duplicate aliquots of antibody?
This archive was generated by hypermail 2b29 : Sat Mar 10 2001 - 19:31:32 EST